Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.6 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |